Gramercy Research Group Approved for $2.1 million Research Funding Award by the Patient-Centered Outcomes Research Institute

Gramercy Research Group has been approved for a $2.1 million funding award by the Patient-Centered Outcomes Research Institute (PCORI) to study chronic disease self-management in African American men. The study is one of 46 proposals PCORI approved for funding on Tuesday, Sept. 30, to advance the field of comparative clinical effectiveness research (CER) and provide patients, healthcare providers, and other clinical decision makers with information that will help them make better-informed choices.


Researchers from Gramercy Research Group (Melicia C. Whitt-Glover, Ph.D.) and Arizona State University (Steven P. Hooker, Ph.D.), will lead the project. The study will evaluate the impact of an intervention, Active & Healthy Brotherhood, which has been specifically designed to improve health behaviors in African American men. Marcus Murray and Steve Hughes from Project Brotherhood in Chicago, IL will help develop the intervention. A team of six African American men from Forsyth County, NC will also help guide the project.


The award has been approved pending completion of a business and programmatic review by PCORI staff and issuance of a formal award contract to Gramercy Research Group.


“This award is a major win for our team,” says Whitt-Glover. “For several years we have been conducting projects to improve health in women, and men have been asking when they will have a chance to participate. We are excited to bring this special program to African American men in our community!” Active & Healthy Brotherhood is a continuation of a program developed when Dr. Hooker was Director of the Prevention Research Center in the Arnold School of Public Health at the University of South Carolina, Columbia. “We are so thrilled to receive this funding,” says Hooker. “Our initial work showed that Active & Healthy Brotherhood has great promise. The PCORI funding will allow us to further determine the benefits of the program in a larger population, and should go a long way toward improving health in the community.”


“This project was selected for PCORI funding not only for its scientific merit and commitment to engaging patients and other stakeholders, but also for its potential to fill an important gap in our health knowledge and give people information to help them weigh the effectiveness of their care options,” said PCORI Executive Director Joe Selby, MD, MPH. “We look forward to following the study’s progress and working with Gramercy Research Group to share the results.”


Gramercy Research Group’s study and the other projects approved for funding by PCORI were selected from 490 applications that responded fully to PCORI’s funding announcements issued in February 2014. They were selected through a highly competitive review process in which patients, clinicians, and other stakeholders joined clinical scientists to evaluate the proposals. Applications were assessed for scientific merit, how well they will engage patients and other stakeholders, and their methodological rigor among other criteria.


For more information or to become involved with the Active & Healthy Brotherhood Project, please contact Melicia Whitt-Glover via telephone at (336) 293-8540, extension 110, or email: For more information about Gramercy Research Group visit



Gramercy Research Group is an independent research firm focusing on community- and faith-based participatory research, chronic disease prevention, and health disparities.  Dr. Melicia C. Whitt-Glover is President and CEO.


PCORI is an independent, non-profit organization authorized by Congress in 2010 to fund comparative clinical effectiveness research that will provide patients, their caregivers, and clinicians with the evidence-based information needed to make better-informed health and healthcare decisions. PCORI is committed to seeking input from a broad range of stakeholders to guide its work. It has approved $671 million to support 360 research studies and initiatives since it began funding research in 2012. For more information about PCORI funding, visit